The near infrared medical imaging market has been witnessing growth as medical professionals are becoming keen on using non-invasive and real-time imaging technologies for the diagnosis and treatment of diseases. With the near infrared technology, images can be produced by using light wavelengths that are able to pass through biological tissues more easily compared to visible light. Thus, the technology helps to get more accurate pictures of blood vessels, oxygen levels in tissue, lymphatics, and boundaries between tumors. As a result, the near infrared technology has found numerous applications in various fields, including oncology, cardiovascular imaging, neurology, and reconstructive surgeries, without exposing patients to radiation.
The market is further gaining from the increasing prevalence of chronic disease along with the growing demands for image guided procedures. The World Health Organization states that cancer has been responsible for millions of deaths in the world globally. It further indicates the importance of advanced imaging techniques to diagnose and treat cancer. Further, about 17.9 million people die every year due to cardiovascular diseases. The demand for advanced imaging technologies is increasing as a result of this trend. The use of near infrared imaging is being done during cancer surgery to ensure accurate tumor localization and lymph node mapping. Near infrared imaging helps in ensuring blood flow during surgery.
In terms of Product Type, the Near Infrared Fluorescence Imaging Devices segment is projected to dominate the market in 2026 because of their extensive use in real-time tissue visualization, tumor localization, lymph node mapping, and guided surgery. The increase in use of fluorescence-guided procedures in oncology and cardiovascular specialties further contributes to the growth of the segment.
By Application, the Cancer Surgeries segment is anticipated to lead in terms of market share in 2026. Growing incidences of cancer, rising need for accurate tumor detection, and increasing use of fluorescence-guided imaging devices during surgical procedures are fueling the adoption rate. With the help of near infrared imaging, the surgeon can distinguish easily between healthy and cancerous tissues.
Geographically, the North American market is expected to dominate the near infrared medical imaging market in 2026 owing to high prevalence of cancer and neurological diseases, well-developed healthcare infrastructure, active research activities, and continuous innovation of products offered by leading market players. The fastest-growing region is expected to be Asia Pacific in 2026 on account of increasing healthcare investments, rising adoption of imaging technology, and growing collaboration between international and regional medical device companies in countries like Japan, China, and India.
Prominent Players in the Near Infrared Medical Imaging Market
-
Bruker Corporation
Company Overview
- Headquarters: Billerica, Massachusetts, U.S.
- Establishment Year: 1960
- Employee Strength: Approximately 9,700 employees
- Leadership: Frank H. Laukien, President, Chief Executive Officer & Chairman
- Core Services/Products: Scientific instruments, molecular imaging systems, optical imaging technologies, preclinical imaging solutions, and analytical instruments.
SWOT Analysis
- Strengths
- Strong expertise in advanced imaging and analytical technologies.
- Broad portfolio serving life sciences and healthcare markets.
- Weaknesses
- Significant dependence on research and laboratory spending.
- High capital-intensive product portfolio.
- Opportunities
- Growing demand for advanced medical imaging technologies.
- Expansion of molecular and fluorescence imaging applications.
- Threats
- Intense competition from global imaging companies.
- Regulatory and reimbursement challenges.
-
Carl Zeiss Meditec AG
Company Overview
- Headquarters: Jena, Germany
- Establishment Year: 2002
- Employee Strength: Approximately 4,900 employees
- Leadership: Markus Weber, President & Chief Executive Officer
- Core Services/Products: Surgical visualization systems, ophthalmic imaging devices, microscopy solutions, fluorescence-guided imaging technologies, and medical technology systems.
SWOT Analysis
- Strengths
- High brand reputation for optical and surgical imaging.
- State-of-the-art visualization and microscopy technology.
- Weaknesses
- Healthcare capital equipment investment dependence.
- High-cost positioning may affect market acceptance.
- Opportunities
- Increasing use of fluorescence-guided surgery.
- Favorable trend towards minimally invasive surgeries.
- Threats
- Swift competition from other medical imaging firms globally.
- Hospital capital expenditure constraints during economic recessions.
-
Shimadzu Corporation
Company Overview
- Headquarters: Kyoto, Japan
- Establishment Year: 1875
- Employee Strength: Approximately 14,000 employees
- Leadership: Yasunori Yamamoto, President & Chief Executive Officer
- Core Services/Products: Medical imaging systems, analytical instruments, diagnostic equipment, life science technologies, and optical measurement solutions.
SWOT Analysis
- Strengths
- Extensive technical capabilities in imaging and diagnosis.
- Varied range of healthcare and analytical instruments.
- Weaknesses
- Lesser penetration in some Western healthcare market sectors.
- Opportunities
- Emergence of need for superior diagnostic imaging.
- Advancement in the field of precision medicine and research.
- Threats
- Breakthrough in technology requiring continual investments.
- Competition from imaging firms in international markets.
-
PerkinElmer, Inc.
Company Overview
- Headquarters: Waltham, Massachusetts, U.S.
- Establishment Year: 1937
- Leadership: Dirk Bontridder, Chief Executive Officer
- Core Services/Products: Medical imaging systems, life science research solutions, molecular imaging technologies, diagnostics, and laboratory services.
SWOT Analysis
- Strengths
- Capacity in the field of life sciences and diagnostic technologies.
- In-depth knowledge and experience in molecular imaging applications.
- Weaknesses
- Vulnerable to research and healthcare funding.
- Susceptible to changes in laboratory budget.
- Opportunities
- Broadening of precision diagnostics and imaging services.
- Increasing need for cutting-edge biomedical research products.
- Threats
- Competitive environment in life sciences instrumentation.
- Compliance issues in the healthcare industry.
-
MIZUHO Corporation (Mizuho Medical Co., Ltd.)
Company Overview
- Headquarters: Tokyo, Japan
- Establishment Year: 1919
- Leadership: Shigeru Kimura, President & Chief Executive Officer
- Core Services/Products: Surgical equipment, operating room systems, neurosurgical devices, patient positioning systems, and medical imaging support solutions.
SWOT Analysis
- Strengths
- High level of proficiency in surgery and operating theatre technology.
- Reputable in neuro-surgical and other types of surgery support equipment.
- Weaknesses
- Smaller presence globally than other major imaging companies.
- Lower degree of interaction with sophisticated imaging devices.
- Opportunities
- Burgeoning need for surgical operations guided by images.
- Emerging technologies in advanced surgical visualization systems.
- Threats
- The presence of competitors in the field of medical technology.
- Stringent regulations on medical devices.
